The U.S. has reached 600,000 COVID-19 deaths since the pandemic began, though daily fatalities have dropped to an average of 360 after peaking at 3,000 in January. Officials are pushing to vaccinate 70% of adults by July 4. (CNBC Weekly)

Former Food and Drug Administration commissioner Stephen Hahn will join Flagship Pioneering as chief medical officer. The venture capital firm launched Moderna more than a decade ago. (The Washington Post)

Sage Therapeutics’ experimental depression drug zuranolone reached its primary endpoint in a Phase III trial, the company announced. Questions remain, however, over potential side effects. (Endpoints News)

COVID-19 survivors are seeking medical care for health issues they did not have prior to contracting the virus. A new study, the largest completed on long-term COVID-19 symptoms, found that nearly a quarter of COVID-19 survivors were treated for new conditions within a month of infection. (The New York Times)

Researchers at the University of Minnesota are hoping to treat advanced gastrointestinal cancers with CRISPR-edited immune cells. The approach combines CRISPR and T cell therapy in an effort to target solid tumors. (STAT)